Merck KGaA has become the second large German pharmaceutical company to reconfigure its profile with the acquisition of Sigma-Aldrich Co for $17 billion. The deal, announced on 22 September, has been approved by the boards of both companies. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
